Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1109 (13 May), doi:10.1136/bmj.332.7550.1109-a
Madeleine Brettingham
London
| The first 150 words of the full text of this article appear below. |
The Drug and Therapeutics Bulletin, a journal that has provided doctors across England with advice about medical treatments for over 40 years, has had its funding stopped by the Department of Health in the latest round of cost cutting in the NHS.
The last minute decision, which came only two hours before the bulletin's previous contract ended in March, leaves the publication's future uncertain and threatens to increase yet further the influence of the drug industry in doctors' prescribing, said its editor, Ike Iheanacho.
"In April last year the [parliamentary] health select committee pointed to us as an invaluable source of independent advice. So it seems strange that they have done this. The fear is that now doctors will be reliant on pharmaceutical promotion," Dr Iheanacho said.
"We have an unrivalled reputation for looking critically at the information on offer and giving doctors practical guidance, and many have told
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.